NEW YORK (GenomeWeb) – Interpace Diagnostics announced today that it has signed a laboratory services agreement to provide its molecular thyroid tests to researchers at Einstein Medical Center of Philadelphia.
Under the terms of the deal, Einstein's endocrinologists and otolaryngologists will have access to Interpace's ThyGenX oncogene panel and ThyraMir microRNA gene expression classifier, which are used to diagnose thyroid nodules with indeterminate cytology.
Additional terms were not disclosed.
"This new contract continues the strong trend we have seen in the number of new laboratory services agreements we have executed in just the past few months," Interpace President and CEO Jack Stover said in a statement.